Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

BACKGROUND: Preclinical data support further investigation of ascorbic acid in pancreatic cancer. There are currently insufficient safety data in human subjects, particularly when ascorbic acid is combined with chemotherapy. METHODS AND FINDINGS: 14 subjects with metastatic stage IV pancreatic cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Monti, Daniel A., Mitchell, Edith, Bazzan, Anthony J., Littman, Susan, Zabrecky, George, Yeo, Charles J., Pillai, Madhaven V., Newberg, Andrew B., Deshmukh, Sandeep, Levine, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260161/
https://www.ncbi.nlm.nih.gov/pubmed/22272248
http://dx.doi.org/10.1371/journal.pone.0029794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260161/
https://www.ncbi.nlm.nih.gov/pubmed/22272248
http://dx.doi.org/10.1371/journal.pone.0029794

Ejemplares similares